108 related articles for article (PubMed ID: 23886329)
1. Global health priorities and research funding.
Ghinai I; Hla TT; Smith R
Lancet Infect Dis; 2013 Aug; 13(8):653. PubMed ID: 23886329
[No Abstract] [Full Text] [Related]
2. Global health priorities and research funding.
Catalá-López F; Gènova-Maleras R; Peiró S
Lancet Infect Dis; 2013 Aug; 13(8):652. PubMed ID: 23886327
[No Abstract] [Full Text] [Related]
3. Global health priorities and research funding--authors' reply.
Head MG; Fitchett JR; Atun R
Lancet Infect Dis; 2013 Aug; 13(8):653. PubMed ID: 23886328
[No Abstract] [Full Text] [Related]
4. Mapping the terrain of investment in global infectious diseases.
Kyratsis Y; Ahmad R
Lancet Infect Dis; 2013 Jan; 13(1):6-7. PubMed ID: 23140943
[No Abstract] [Full Text] [Related]
5. UK investments in global infectious disease research 1997-2010: a case study.
Head MG; Fitchett JR; Cooke MK; Wurie FB; Hayward AC; Atun R
Lancet Infect Dis; 2013 Jan; 13(1):55-64. PubMed ID: 23140942
[TBL] [Abstract][Full Text] [Related]
6. Global health and the scientific research agenda.
Flory JH; Kitcher P
Philos Public Aff; 2004; 32(1):36-65. PubMed ID: 15658019
[No Abstract] [Full Text] [Related]
7. In Search of a Proportionate Funding in Medicine.
Baquerizo Nole KL; Fox JD; Kirsner RS
JAMA Dermatol; 2015 Jun; 151(6):583-4. PubMed ID: 25714756
[No Abstract] [Full Text] [Related]
8. Where does public funding for cancer research go: Allocation of research funding for cancer and COPD is not always proportional to disease burden.
Trasta A
EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29459482
[TBL] [Abstract][Full Text] [Related]
9. WHO's budgetary allocations and burden of disease: a comparative analysis.
Stuckler D; King L; Robinson H; McKee M
Lancet; 2008 Nov; 372(9649):1563-9. PubMed ID: 18984189
[TBL] [Abstract][Full Text] [Related]
10. [Resource to medical research should be doubled].
Røttingen JA
Tidsskr Nor Laegeforen; 2005 May; 125(9):1220-1. PubMed ID: 15880168
[No Abstract] [Full Text] [Related]
11. Show me the money! An analysis of underserved stakeholders' funding priorities in Patient Centered Outcomes Research domains.
Cargill SS; Baker LL; Goold SD
J Comp Eff Res; 2017 Jul; 6(5):449-459. PubMed ID: 28686060
[TBL] [Abstract][Full Text] [Related]
12. Resource allocation to brain research in Europe.
Sørensen PS
Eur J Neurol; 2007 Jun; 14(6):597. PubMed ID: 17539933
[No Abstract] [Full Text] [Related]
13. Autism research funding allocation: can economics tell us if we have got it right?
Zwicker JD; Emery JC
Autism Res; 2014 Dec; 7(6):704-11. PubMed ID: 25288440
[TBL] [Abstract][Full Text] [Related]
14. Resource allocation to brain research in Denmark: an example for other European countries.
Olesen J; Lekander I; Sobocki P
Eur J Neurol; 2007 Jun; 14(6):667-71. PubMed ID: 17539947
[TBL] [Abstract][Full Text] [Related]
15. China rushes through major funding system.
Cyranoski D
Nature; 2008 Sep; 455(7210):142. PubMed ID: 18784681
[No Abstract] [Full Text] [Related]
16. Resource allocation to brain research in Europe (RABRE).
Sobocki P; Lekander I; Berwick S; Olesen J; Jönsson B
Eur J Neurosci; 2006 Nov; 24(10):2691-3. PubMed ID: 17156195
[TBL] [Abstract][Full Text] [Related]
17. Funding resources for rare disease research.
Stehr F; Forkel M
Biochim Biophys Acta; 2013 Nov; 1832(11):1910-2. PubMed ID: 23608548
[TBL] [Abstract][Full Text] [Related]
18. Medical research in India and the rise of non-communicable disease.
Jain V
BMJ; 2016 Jun; 353():i3371. PubMed ID: 27358280
[No Abstract] [Full Text] [Related]
19. [The French health care funding system for research and innovation in oncology].
Wiernik H; Katz G; Coulonjou H; Salagnac A; Kletz F; Thariat J
Bull Cancer; 2018 Jun; 105(6):581-595. PubMed ID: 29747854
[TBL] [Abstract][Full Text] [Related]
20. [High societal costs of brain diseases. Extremely small resources allocated to research on prevention and treatment].
Sobocki P; Allgulander C; Hillert J; Jönsson B
Lakartidningen; 2007 May 14-29; 104(20-21):1590-4. PubMed ID: 17564267
[No Abstract] [Full Text] [Related]
[Next] [New Search]
